This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 May;18(5):559-561.

doi: 10.1016/S1470-2045(17)30191-2.

Immune checkpoint inhibitors in malignant pleural mesothelioma

Giovanni Luca Ceresoli¹, Alberto Mantovani²

Affiliations

Affiliations

¹ Thoracic and GU Oncology Unit, Department of Medical Oncology, Cliniche Humanitas Gavazzeni, 24125 Bergamo, Italy. Electronic address: giovanni_luca.ceresoli@gavazzeni.it.
² Humanitas University, Istituto Clinico Humanitas IRCCS, Milan, Italy.

PMID: 28495276
DOI: 10.1016/S1470-2045(17)30191-2

Comment

Immune checkpoint inhibitors in malignant pleural mesothelioma

Giovanni Luca Ceresoli et al. Lancet Oncol. 2017 May.

. 2017 May;18(5):559-561.

doi: 10.1016/S1470-2045(17)30191-2.

Authors

Giovanni Luca Ceresoli¹, Alberto Mantovani²

Affiliations

¹ Thoracic and GU Oncology Unit, Department of Medical Oncology, Cliniche Humanitas Gavazzeni, 24125 Bergamo, Italy. Electronic address: giovanni_luca.ceresoli@gavazzeni.it.
² Humanitas University, Istituto Clinico Humanitas IRCCS, Milan, Italy.

PMID: 28495276
DOI: 10.1016/S1470-2045(17)30191-2

No abstract available

PubMed Disclaimer

Comment on

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.
Alley EW, Lopez J, Santoro A, Morosky A, Saraf S, Piperdi B, van Brummelen E. Alley EW, et al. Lancet Oncol. 2017 May;18(5):623-630. doi: 10.1016/S1470-2045(17)30169-9. Epub 2017 Mar 11. Lancet Oncol. 2017. PMID: 28291584 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information